Atotech (NYSE: ATC), a leading specialty chemicals technology
company and a market leader in advanced electroplating solutions,
today reported record financial results for the second quarter of
2021 and raised its revenue and Adjusted EBITDA guidance for the
full year 2021. Chemistry organic revenue growth, a key performance
indicator for the Company, increased 24% over the second quarter of
2020. Chemistry organic revenue growth reflects chemistry revenue
growth excluding the impact of foreign exchange translation (“FX”)
and palladium pass-through (“palladium”).
Management Commentary
Geoff Wild, Atotech’s Chief Executive Officer
said, “We are very satisfied by our outstanding second quarter
performance. As anticipated, our exposure to secular growth trends
and the continuing economic recovery from the Covid-19 pandemic
have led to a strong recovery of our revenues. Our robust business
model, which combines a lean cost structure and strong operating
leverage, allowed us to translate our excellent revenue growth into
record Adjusted EBITDA and strong Free Cash Flow.”
“The supportive trends we have witnessed since
the beginning of this year, including the build-out of 5G
smartphone production and demand for new solutions in advanced
semiconductor packaging, continue to build momentum. Atotech’s
comprehensive systems and solutions approach, combining leading
R&D capabilities and global reach allows us to leverage that
demand.”
“As expected, in Q2 we saw higher freight costs
from the disruption of global supply chains. However, over the
course of the quarter, these began to improve and we feel confident
in our ability to contain these costs in the second half of
2021.”
Second-quarter 2021 Results
Total revenue was $377 million for the second
quarter of 2021, an increase of 44% over the prior year period.
Total organic revenue, which reflects total revenue excluding the
impact of FX and palladium, increased 32%. FX was a 9% tailwind and
palladium increased total revenue by 3% for the quarter. These
strong quarterly results were driven by organic growth in chemistry
revenue of 24%, reflecting double-digit increases in both the
Electronics (“EL”) and General Metal Finishing (“GMF”)
segments.
Adjusted EBITDA was $118 million for the second
quarter of 2021, a 63% increase over the prior year period,
reflecting strong chemistry organic volume growth, stable pricing,
and FX tailwinds, partially offset by increased costs associated
with supply chain inefficiencies.
Diluted earnings per share was $0.15 for the
period ended June 30, 2021, and Adjusted EPS was $0.29.
Adjusted EBITDA margin was 31% for the second
quarter of 2021, an increase of 370 basis points. The improvement
reflects the revenue recovery from the second quarter of 2020, the
most pandemic-affected quarter last year and operating leverage on
chemistry organic revenue, partially offset by the impact of
palladium pass-through, the product mix of chemistry versus
equipment, and supply chain inefficiencies.
Second-quarter 2021 Segment
Highlights
Electronics: Revenue for the
second quarter of 2021 in our Electronics segment was $248 million,
an increase of 33% over the prior year period. Total organic
revenue grew 21%, consisting of 9% chemistry organic growth and a
115% increase in equipment organic revenue. Palladium pass-through
increased revenue by 4% and FX was an 8% tailwind for the
quarter.
The Electronics organic revenue increase was
driven by sustained high demand for the Company’s advanced
semiconductor packaging and IC substrate solutions. End-market
demand for computing applications and widespread 5G handset
adoption continued to gain momentum in the second quarter.
Similarly, the demand for our equipment continued to accelerate as
PCB and semiconductor manufacturers worldwide increased their
production capacity and upgraded their technology.
Adjusted EBITDA for our Electronics segment was
$85 million for the second quarter of 2021, a 36% increase over the
prior year period, primarily driven by strong chemistry volume
growth. Adjusted EBITDA margin increased by 70 basis points to
34.3%, reflecting operating leverage on chemistry organic growth,
offset by a product-mix effect from lower gross margin equipment
revenues.
General Metal Finishing:
Revenue for the second quarter of 2021 in our GMF segment was $129
million, an increase of 71% over the prior year period. Total
organic GMF revenue increased 59%, consisting of 59% chemistry
organic revenue growth and a 48% increase in organic revenue for
equipment. Palladium and FX added 1% and 11% to revenue for the
quarter, respectively.
Chemistry organic revenue growth was primarily a
function of recovery from the pandemic-depressed markets of the
prior-year quarter, supported by the continued end-market recovery,
especially automotive and construction.
Adjusted EBITDA for our GMF segment was $33
million, a 238% increase over last year, reflecting operating
leverage on chemistry volume growth, partially offset by supply
chain inefficiencies. Adjusted EBITDA margin increased by nearly 13
percentage points to 25.8% driven by the same effects.
Full Year 2021 Guidance
Regarding the Company’s 2021 outlook, Peter
Frauenknecht, Atotech’s Chief Financial Officer said, “As a result
of our very strong first half and our improved outlook for the
second half of the year, we are raising our revenue and Adjusted
EBITDA guidance. We now expect full year 2021 total organic revenue
growth to be in the range of 13% to 14%, including full year
organic growth in chemistry revenue of approximately 10%, which
excludes the impact of FX and palladium pass-through. Additionally,
we now expect full year 2021 adjusted EBITDA to be in the range of
$435 million to $450 million, which represents a $18 million
improvement over our prior guidance, at the mid-point.”
MKS Transaction
On July 1, 2021, MKS Instruments, Inc. (“MKS”),
a global provider of technologies that enable advanced processes
and improve productivity, and Atotech Limited announced that they
entered into a definitive agreement pursuant to which MKS will
acquire Atotech for $16.20 in cash and 0.0552 of a share of MKS
common stock for each Atotech common share (the “MKS Transaction”).
The transaction was unanimously approved by the MKS and Atotech
boards of directors and is subject to Atotech shareholder approval,
approval of the Royal Court of Jersey, regulatory approvals, and
other customary closing conditions, and is expected to close by the
fourth quarter of 2021.
Conference Call
The Company will host a conference call today at
8:00 a.m. Eastern time to discuss the second quarter results only.
There will be no discussion of the MKS Transaction. A link to the
live audio webcast, and associated presentation materials will be
available on the Company website at Events & presentations |
Atotech. If you would like to ask a question, the dial-in number
is: +1 833 714-3263 (United States/Canada toll-free) or +1 270
823-1866 (International toll), using conference ID 4774516.
Cautionary Statement Regarding
Forward-Looking Statements
This communication contains “forward-looking
statements” within the meaning of the federal securities laws,
including Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
In this context, forward-looking statements often address expected
future business and financial performance and financial condition,
and often contain words such as “expect,” “anticipate,” “intend,”
“plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” and
similar expressions and variations or negatives of these words.
These forward-looking statements, which are
subject to risks, uncertainties, and assumptions about us, may
include projections of our future financial performance, our
anticipated growth strategies, and anticipated trends in our
business. These statements are only predictions based on our
current expectations and projections about future events. There are
important factors that could cause our actual results, level of
activity, performance or achievements to differ materially from the
results, level of activity, performance or achievements expressed
or implied by the forward-looking statements, and such differences
could be material. We undertake no obligation to publicly update or
revise any forward-looking statements to reflect subsequent events
or circumstances.
More information on potential factors that could
affect Atotech’s financial results is available in “Forward-Looking
Statements”, the “Risk Factors” and “Management's Discussion and
Analysis of Financial Condition and Results of Operations” within
Atotech’s most recent Annual Report on Form 20-F, and in other
documents that we have filed with, or furnished to, the U.S.
Securities and Exchange Commission (the “SEC”), and such factors
include, but are not limited to: the uncertainty of the magnitude,
duration, geographic reach, impact on the global economy of the
COVID 19 pandemic, as well as the current and potential travel
restrictions, stay at home orders, and other economic restrictions
implemented to address it; uncertainty, downturns, and changes in
our target markets; foreign currency exchange rate fluctuations;
reduced market acceptance and inability to keep pace with evolving
technology and trends; loss of customers; increases in costs or
reductions in the supplies of raw materials that may materially
adversely affect our business, financial condition, and results of
operations; our ability to provide products and services in light
of changing environmental, health and safety, product liability,
financial, and other legislation and regulation; our failure to
compete successfully in product development; our ability to
successfully execute our growth initiatives, business strategies,
and operating plans; whether the secular trends we expect to drive
growth in our business materialize to the degree we expect them to,
or at all; material costs relating to environmental and health and
safety requirements or liabilities; underfunded defined benefit
pension plans; risk that the insurance we maintain may not fully
cover all potential exposures; failure to comply with the
anti-corruption laws of the United States and various international
jurisdictions; tariffs, border adjustment taxes, or other adverse
trade restrictions and impacts on our customers’ value chains;
political, economic, and legal uncertainties in China, the Chinese
government’s control of currency conversion and expatriation of
funds, and the Chinese government’s policy on foreign investment in
China; regulations around the production and use of chemical
substances that affect our products; the United Kingdom’s
withdrawal from the European Union; weak intellectual property
rights in jurisdictions outside the United States; intellectual
property infringement and product liability claims; our substantial
indebtedness; our ability to obtain additional capital on
commercially reasonable terms may be limited; risks related to our
derivative instruments; our ability to attract, motivate, and
retain senior management and qualified employees; increased risks
to our global operations including, but not limited to, political
instability, acts of terrorism, taxation, and unexpected regulatory
and economic sanctions changes, among other things; natural
disasters that may materially adversely affect our business,
financial condition, and results of operations; the inherently
hazardous nature of chemical manufacturing that could result in
accidents that disrupt our operations and expose us to losses or
liabilities; damage to our brand reputation; Carlyle’s ability to
control our common shares; risks relating to the proposed MKS
Transaction, including that such transaction may not be
consummated, any statements of belief and any statements of
assumptions underlying any of the foregoing; and other factors
beyond our control.
Additional Information and Where to Find
It
This communication does not constitute a
solicitation of any vote or approval. In connection with the
proposed MKS Transaction, Atotech plans to provide to its
shareholders a circular containing information on the anticipated
scheme of arrangement vote regarding the proposed MKS Transaction
(the “Scheme Circular”). Atotech may also file other documents with
the SEC regarding the proposed MKS Transaction. This document is
not a substitute for the Scheme Circular or any other document that
may be filed by Atotech with the SEC.
BEFORE MAKING ANY VOTING DECISION, ATOTECH’S
SHAREHOLDERS ARE URGED TO READ THE SCHEME CIRCULAR IN ITS ENTIRETY
WHEN IT BECOMES AVAILABLE AND ANY OTHER DOCUMENTS FILED BY ATOTECH
WITH THE SEC IN CONNECTION WITH THE PROPOSED MKS TRANSACTION OR
INCORPORATED BY REFERENCE THEREIN BEFORE MAKING ANY VOTING OR
INVESTMENT DECISION WITH RESPECT TO THE PROPOSED MKS TRANSACTION
BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MKS
TRANSACTION AND THE PARTIES TO THE PROPOSED MKS TRANSACTION.
Any vote in respect of resolutions to be
proposed at Atotech shareholder meetings to approve the proposed
MKS Transaction, the scheme of arrangement or related matters, or
other responses in relation to the proposed MKS Transaction, should
be made only on the basis of the information contained in Atotech’s
Scheme Circular. Shareholders may obtain a free copy of the Scheme
Circular and other documents Atotech files with the SEC (when
available) through the website maintained by the SEC at
www.sec.gov. Scheme Circular makes available free of charge on its
investor relations website at investors.atotech.com copies of
materials it files with, or furnishes to, the SEC.
No Offer or Solicitation
This communication is for information purposes
only and is not intended to and does not constitute, or form part
of, an offer, invitation or the solicitation of an offer or
invitation to purchase, otherwise acquire, subscribe for, sell or
otherwise dispose of any securities, or the solicitation of any
vote or approval in any jurisdiction, pursuant to the proposed MKS
Transaction or otherwise, nor shall there be any sale, issuance or
transfer of securities in any jurisdiction in contravention of
applicable law.
The proposed MKS Transaction will be implemented
solely pursuant to the scheme of arrangement, subject to the terms
and conditions of the definitive agreement between MKS and Atotech,
dated July 1, 2021, which contains the full terms and conditions of
the proposed MKS Transaction.
Non-IFRS Financial Measures
This communication contains certain non-IFRS
financial measures designed to complement the financial information
presented in accordance with IFRS because management believes such
measures are useful to investors. However, our use of these
non-IFRS financial measures may vary from that of others in our
industry. Our non-IFRS metrics have limitations as analytical
tools, and you should not consider them in isolation or as
alternatives to consolidated net income (loss) or other performance
measures derived in accordance with IFRS as measures of operating
performance, operating cash flows or liquidity. The Company
believes that these measures are important and supplement
discussions and analysis of its results of operations and enhances
an understanding of its operating performance. See the Appendix for
a reconciliation of the non-IFRS financial measures.
About Atotech
Atotech is a leading specialty chemicals
technology company and a market leader in advanced electroplating
solutions. Atotech delivers chemistry, equipment, software, and
services for innovative technology applications through an
integrated systems-and-solutions approach. Atotech solutions are
used in a wide variety of end-markets, including smartphones and
other consumer electronics, communications infrastructure, and
computing, as well as in numerous industrial and consumer
applications such as automotive, heavy machinery, and household
appliances.
Atotech, headquartered in Berlin, Germany, is a
team of 4,000 experts in over 40 countries generating annual
revenues of $1.2 billion (2020). Atotech has manufacturing
operations across Europe, the Americas, and Asia. With its
well-established innovative strength and industry-leading global
TechCenter network, Atotech delivers pioneering solutions combined
with unparalleled on-site support for over 9,000 customers
worldwide. For more information about Atotech, please visit us at
atotech.com.
Financial Statement Tables
ATOTECH LIMITED Income
Statement
|
Three months
ended (unaudited) |
($ in millions), except earnings per share |
June 30, 2021 |
June 30, 2020 |
Revenue |
$ |
376.6 |
|
$ |
260.9 |
|
Cost of sales, excluding
depreciation and amortization |
|
(185.9 |
) |
|
(121.7 |
) |
Depreciation and
amortization |
|
(43.8 |
) |
|
(319.2 |
) |
Selling, general and
administrative expenses |
|
(61.3 |
) |
|
(59.4 |
) |
Research and development
expenses |
|
(13.2 |
) |
|
(11.2 |
) |
Restructuring benefit
(expenses) |
|
0.6 |
|
|
(1.7 |
) |
Operating profit
(loss) |
|
72.9 |
|
|
(252.3 |
) |
Interest expense |
|
(14.5 |
) |
|
(36.3 |
) |
Other income (expense),
net |
|
(4.1 |
) |
|
18.6 |
|
Income (loss) before
income taxes |
|
54.3 |
|
|
(269.9 |
) |
Income tax expense |
|
(24.6 |
) |
|
(13.0 |
) |
Consolidated net
income (loss) |
$ |
29.7 |
|
$ |
(282.9 |
) |
Earnings per share |
|
|
Basic earnings (loss) per
share |
|
0.15 |
|
|
(3.47 |
) |
Diluted earnings (loss) per
share |
|
0.15 |
|
|
(3.47 |
) |
|
Three months
ended (unaudited) |
($ in millions) |
June 30, 2021 |
June 30, 2020 |
Consolidated net income (loss) |
$ |
29.7 |
|
$ |
(282.9 |
) |
Other comprehensive
income (loss) |
|
|
Actuarial gains and
losses |
|
(0.9 |
) |
|
(7.2 |
) |
Tax effect |
|
0.3 |
|
|
2.1 |
|
Items not potentially
reclassifiable to statement of income |
|
(0.7 |
) |
|
(5.1 |
) |
Currency translation
adjustment |
|
27.2 |
|
|
36.4 |
|
Hedge reserve |
|
(0.4 |
) |
|
(4.0 |
) |
Thereof: Income (cost) of
Hedging (OCI II) |
|
0.7 |
|
|
(1.8 |
) |
Items potentially
reclassifiable to statement of income (loss), net of
tax |
|
26.8 |
|
|
32.4 |
|
Total other
comprehensive income (loss), net amount |
$ |
26.2 |
|
$ |
27.3 |
|
Comprehensive
loss |
$ |
55.8 |
|
$ |
(255.6 |
) |
ATOTECH LIMITED Condensed
Consolidated Balance Sheets
|
As of |
($ in millions) |
June 30, 2021 |
Dec. 31, 2020 |
Assets |
(unaudited) |
(audited) |
Non-current
assets |
|
|
Property, plant and equipment |
$ |
341.2 |
$ |
359.4 |
Intangible assets |
|
1,410.8 |
|
1,471.0 |
Goodwill |
|
796.9 |
|
804.1 |
Right-of-use assets |
|
95.5 |
|
104.1 |
Other financial assets |
|
5.8 |
|
70.3 |
Other non-financial
assets |
|
3.6 |
|
2.7 |
Total non-current
assets |
|
2,653.9 |
|
2,811.6 |
Current
assets |
|
|
Inventories |
|
172.9 |
|
145.4 |
Trade receivables* |
|
258.5 |
|
262.0 |
Other financial assets* |
|
18.4 |
|
24.9 |
Other non-financial
assets* |
|
34.2 |
|
24.1 |
Tax assets |
|
50.5 |
|
46.4 |
Cash and cash equivalents |
|
249.4 |
|
320.1 |
Total current
assets |
|
783.9 |
|
822.9 |
Total
assets |
$ |
3,437.8 |
$ |
3,634.5 |
Liabilities &
shareholders’ equity |
|
|
Shareholders’
equity |
|
|
Common shares and preferred
shares |
|
19.5 |
|
102.1 |
Paid-in surplus and retained
earnings |
|
772.0 |
|
261.6 |
Currency translation
adjustment and other reserves |
|
91.2 |
|
120.0 |
Total shareholders’
equity |
|
882.7 |
|
483.7 |
Non-current
liabilities |
|
|
Borrowings |
$ |
1,560.7 |
$ |
2,065.7 |
Deferred tax liabilities |
|
324.6 |
|
340.8 |
Employee benefits |
|
161.2 |
|
176.2 |
Provisions |
|
13.4 |
|
13.2 |
Lease liabilities |
|
61.1 |
|
67.7 |
Other financial
liabilities |
|
0.0 |
|
1.5 |
Total non-current
liabilities |
|
2,120.9 |
|
2,665.1 |
Current liabilities |
|
|
Borrowings |
|
7.3 |
|
0.5 |
Trade payables |
|
216.3 |
|
221.0 |
Tax liabilities |
|
87.3 |
|
99.2 |
Lease liabilities |
|
13.7 |
|
13.8 |
Other financial
liabilities |
|
18.5 |
|
38.5 |
Other non-financial
liabilities |
|
74.5 |
|
89.7 |
Provisions |
|
16.5 |
|
23.0 |
Total current
liabilities |
|
434.1 |
|
485.8 |
Total liabilities
& shareholders’ equity |
$ |
3,437.8 |
$ |
3,634.5 |
ATOTECH LIMITED Consolidated
Statement of Cash Flows
|
Six months
ended (unaudited) |
($ in millions) |
June 30, 2021 |
June 30, 2020 |
Operating
activities |
|
|
Consolidated net income (loss) |
$ |
(41.9 |
) |
$ |
(322.8 |
) |
Adjustments to reconcile net
income (loss) to cash provided by operating activities: |
|
|
Depreciation and
amortization |
|
88.4 |
|
|
360.3 |
|
Income taxes and changes in
non-current provisions |
|
31.0 |
|
|
20.4 |
|
(Gains)/losses on disposals of
assets |
|
0.5 |
|
|
0.2 |
|
Net (gain)/loss on financial
instruments at fair value |
|
40.8 |
|
|
10.1 |
|
Accrued financial interest
costs |
|
44.9 |
|
|
64.4 |
|
Amortization of deferred
financing cost, including original issuance discounts |
|
55.4 |
|
|
7.5 |
|
Interest paid |
|
(43.1 |
) |
|
(64.5 |
) |
Taxes paid |
|
(64.6 |
) |
|
(28.8 |
) |
Other |
|
(5.7 |
) |
|
0.8 |
|
(Increase)/decrease in
inventories |
|
(30.0 |
) |
|
(33.1 |
) |
(Increase)/decrease in trade
receivables |
|
3.3 |
|
|
35.9 |
|
Increase/(decrease) in trade
payables |
|
0.9 |
|
|
(20.9 |
) |
Changes in other assets and
liabilities |
|
(43.4 |
) |
|
(20.6 |
) |
Cash flow provided by
operating activities |
|
36.8 |
|
|
8.8 |
|
Investing
activities |
|
|
Intangible assets and
property, plant and equipment additions |
|
(22.1 |
) |
|
(22.7 |
) |
Increase in non-current
loans |
|
(0.1 |
) |
|
(0.0 |
) |
Proceeds from disposals of
intangible assets and property, plant and equipment |
|
3.3 |
|
|
0.1 |
|
Repayments of non-current
loans |
|
0.1 |
|
|
0.2 |
|
Cash flow used in
investing activities |
|
(18.8 |
) |
|
(22.4 |
) |
Financing
activities |
|
|
Issuance of shares |
|
473.4 |
|
|
— |
|
Issuance of non-current
debt |
|
130.1 |
|
|
175.0 |
|
Repayment of non-current
debt |
|
(678.9 |
) |
|
(83.0 |
) |
Increase (decrease) in current
borrowings and bank debt |
|
2.1 |
|
|
(1.4 |
) |
Increase (decrease) in current
financial assets and liabilities |
|
(0.2 |
) |
|
(0.3 |
) |
Payment of lease
liabilities |
|
(7.8 |
) |
|
(7.2 |
) |
Payment of deferred finance
costs |
|
— |
|
|
(9.2 |
) |
Cash flow used in
financing activities |
|
(81.3 |
) |
|
73.9 |
|
Net decrease in cash
and cash equivalents |
|
(63.3 |
) |
|
60.3 |
|
Effect of exchange rates |
|
(7.3 |
) |
|
(3.7 |
) |
Cash and cash equivalents at
the beginning of the period |
|
320.0 |
|
|
302.7 |
|
Cash and cash
equivalents at the end of the period |
$ |
249.4 |
|
$ |
359.3 |
|
ATOTECH LIMITED Revenue Data
|
Three months
ended (unaudited) |
($ in millions) |
June 30, 2021 |
June 30, 2020 |
Type of goods or
service |
|
|
Chemistry revenue |
$ |
325.3 |
$ |
238.1 |
Equipment revenue |
|
51.3 |
|
22.8 |
Total revenue from
contracts with customers |
|
376.6 |
|
260.9 |
Geographical
market |
|
|
Asia |
|
271.3 |
|
202.7 |
Europe |
|
75.3 |
|
41.9 |
Americas |
|
29.9 |
|
16.4 |
Total revenue from
contracts with customers |
$ |
376.6 |
$ |
260.9 |
ATOTECH LIMITED Segment Data
|
Three months
ended (unaudited) |
|
June 30, 2021 |
June 30, 2020 |
($ in
millions) |
EL |
GMF |
Total |
EL |
GMF |
Total |
Revenue |
$ |
247.5 |
$ |
129.0 |
$ |
376.6 |
$ |
185.7 |
$ |
75.3 |
$ |
260.9 |
thereof Chemistry revenue |
|
197.9 |
|
127.4 |
|
325.3 |
|
163.8 |
|
74.3 |
|
238.1 |
thereof Equipment revenue |
|
49.7 |
|
1.6 |
|
51.3 |
|
21.8 |
|
1.0 |
|
22.8 |
Segment Adjusted EBITDA |
|
84.9 |
|
33.2 |
|
118.1 |
|
62.5 |
|
9.8 |
|
72.3 |
ATOTECH LIMITED Reconciliation
of Adjusted EBITDA to Consolidated Net Income (Loss)
|
Three months
ended (unaudited) |
($ in millions) |
June 30, 2021 |
June 30, 2020 |
Consolidated net income (loss) |
$ |
29.7 |
|
$ |
(282.9 |
) |
Interest expense, net |
|
14.2 |
|
|
36.0 |
|
Income taxes |
|
24.6 |
|
|
13.0 |
|
Depreciation and amortization
(excluding impairment charges) |
|
44.1 |
|
|
40.1 |
|
EBITDA |
$ |
112.6 |
|
$ |
(193.9 |
) |
Non-cash adjustments(a) |
|
(1.4 |
) |
|
257.2 |
|
Foreign exchange loss(b) |
|
5.3 |
|
|
3.1 |
|
Restructuring(c) |
|
(0.6 |
) |
|
1.7 |
|
Transaction related
costs(d) |
|
1.5 |
|
|
1.6 |
|
Management fee(e) |
|
0.5 |
|
|
1.2 |
|
COVID-19 adjustment(f) |
|
0.3 |
|
|
1.3 |
|
Adjusted EBITDA |
$ |
118.1 |
|
$ |
72.3 |
|
thereof EL Segment Adjusted
EBITDA |
$ |
84.9 |
|
$ |
62.5 |
|
thereof GMF Segment Adjusted
EBITDA |
$ |
33.2 |
|
$ |
9.8 |
|
(a) Eliminates the non-cash impact of (1) share based
compensation, (2) losses on the sale of fixed assets, (3)
impairment charges and (4) mark to market adjustments related to
our foreign currency derivatives entered into in connection with
certain redenomination transactions not linked to underlying
individual transactions and bifurcated embedded derivatives related
to certain redemption features of the 6.250% Senior Notes due 2025
(the “Opco Notes”) and 8.75%/9.50% Senior PIK Toggle Notes (the
“Holdco Notes”), and (5) valuation adjustments from the revaluation
of the earn-out liability initially recognized in 2019. The dollar
value of these non-cash adjustments for each period presented above
is set forth below:
|
Three months
ended (unaudited) |
($ in millions) |
June 30, 2021 |
June 30, 2020 |
Share based compensation |
$ |
1.7 |
|
$ |
0.1 |
|
Losses on the sale of fixed
assets |
|
0.4 |
|
|
0.0 |
|
Impairment charges |
|
(0.3 |
) |
|
279.1 |
|
Mark-to-market
adjustments |
|
(3.3 |
) |
|
(22.0 |
) |
Valuation adjustments |
|
- |
|
|
- |
|
Non-cash
adjustments |
$ |
(1.4 |
) |
$ |
257.2 |
|
|
|
|
|
(b) Eliminates net foreign currency transactional gains and
losses on balance sheet items. (c) Eliminates charges resulting
from restructuring activities principally from the Company’s cost
reduction efforts. (d) Reflects an adjustment to eliminate (1) IPO
related costs, linked to the existing equity and (2) professional
fees paid to third party advisors in connection with the
implementation of strategic initiatives. (e) Reflects an adjustment
to eliminate fees paid to Carlyle. The consulting agreement
pursuant to which management fees are paid to Carlyle will
terminate on the earlier of (i) the second anniversary of the IPO
and (ii) the date upon which Carlyle ceases to own more than ten
percent of the outstanding voting securities of the Company.
Management does not view these fees as indicative of the Company’s
operational performance and the removal of these fees from Adjusted
EBITDA is consistent with the calculation of similar measures under
our old senior secured credit facilities and our new credit
agreement as well as the indentures that previously governed the
Holdco Notes and Opco Notes. For a description of the consulting
agreement with Carlyle, see Item 7.B. “Major Shareholders and
Related Party Transactions—Related Party Transactions” in our
Annual Report on Form 20-F. (f) Eliminates charges in connection
with masks, sanitizers, and other COVID-19 related expenses at
certain plant and office locations.
ATOTECH LIMITED Organic Revenue
Growth Reconciliation
|
Three months ended June 30,
2021 (unaudited) |
|
Reported Revenue Growth |
Impact of Currency |
Palladium Pass-Through |
Organic Growth |
|
|
|
|
|
Electronics |
33% |
(8%) |
(4%) |
21% |
General Metal Finishing |
71% |
(11%) |
(1%) |
59% |
Total |
44% |
(9%) |
(3%) |
32% |
_________________________________
1 Adjusted EBITDA is a non-IFRS financial
measure. Adjusted EBITDA should be considered in addition to, but
not as a substitute for, the information provided in accordance
with IFRS. A reconciliation for adjusted EBITDA to the most
directly comparable IFRS financial measure is provided in the
Reconciliation of Adjusted EBITDA to Consolidated Net Income (Loss)
table. We are not able to forecast Consolidated net income (loss)
on a forward-looking basis without unreasonable efforts due to the
high variability and difficulty in predicting certain items that
affect Consolidated net income (loss), including, but not limited
to, Income taxes, Interest expense, and Foreign exchange income
(loss).
Contacts:
Sarah Spray
+1 803 504 4731
sarah.spray@atotech.com
Susanne Richter
+49 30 349 85 418
press@atotech.com
Atotech (NYSE:ATC)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Atotech (NYSE:ATC)
Historical Stock Chart
Von Apr 2023 bis Apr 2024